sponsored links

FDA to Hear Appeal on Breast Cancer Drug (HealthDay)

June 29th, 2011 admin Posted in salud publica | No Comments »

Sponsored Links

HealthDay – TUESDAY, June 28 (HealthDay News) — The controversial cancer drug Avastin becomes the focus of U. S. regulators’ attention again Tuesday during a two-day hearing to determine if the medication can keep its FDA approval for the treatment of metastatic breast cancer.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.

«
»